Europe
Pharnext SA, a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big genomics data and artificial intelligence, announced its financial results for first-half 2019.
MetrioPharm AG, a clinical stage biopharmaceutical company, reports positive results from its recently completed Phase II dose finding study of MP1032 in psoriasis patients.
Pharming categorically denies having had any involvement in the alleged abstraction of proprietary information by Dr Joseph Chiao from his former employer CSL
Life Science Integrates welcomes you to this year’s Pharma Integrates conference in London on 18th and 19th November
Recent research from the University of Eastern Finland revealed increased inflammatory activity in a subgroup of patients with frontotemporal dementia Increased inflammation was associated with parkinsonism symptoms and more rapid disease progression.
Sherrington and Whitehead Buildings combine with new Bellhouse Building in 100,000 sq ft innovation centre
Companies from across the globe provide business and pipeline updates.
The primary endpoint of the trial was improving overall response rate at Day 28 with Jakafi compared to the best available therapy.
Adaptate will build on GammaDelta’s expertise in modulating gammadelta T-cell activity using antibodies, with a focus on developing an immune response to cancer.
AmerisourceBergen, McKesson and Cardinal Health are in the midst of negotiations for a multi-billion settlement over litigation filed against each of the companies for their role in distributing opioid drugs across the country.
PRESS RELEASES